963 related articles for article (PubMed ID: 9603117)
21. Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD.
Fan VS; Ramsey SD; Make BJ; Martinez FJ
COPD; 2007 Mar; 4(1):29-39. PubMed ID: 17364675
[TBL] [Abstract][Full Text] [Related]
22. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease.
Seemungal T; Harper-Owen R; Bhowmik A; Moric I; Sanderson G; Message S; Maccallum P; Meade TW; Jeffries DJ; Johnston SL; Wedzicha JA
Am J Respir Crit Care Med; 2001 Nov; 164(9):1618-23. PubMed ID: 11719299
[TBL] [Abstract][Full Text] [Related]
23. Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease.
Hajiro T; Nishimura K; Tsukino M; Ikeda A; Oga T
Respir Med; 2000 Sep; 94(9):841-6. PubMed ID: 11001074
[TBL] [Abstract][Full Text] [Related]
24. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease.
Osman IM; Godden DJ; Friend JA; Legge JS; Douglas JG
Thorax; 1997 Jan; 52(1):67-71. PubMed ID: 9039248
[TBL] [Abstract][Full Text] [Related]
25. Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease.
Hajiro T; Nishimura K; Tsukino M; Ikeda A; Koyama H; Izumi T
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):785-90. PubMed ID: 9517591
[TBL] [Abstract][Full Text] [Related]
26. Impact of comorbidities on COPD-specific health-related quality of life.
Burgel PR; Escamilla R; Perez T; Carré P; Caillaud D; Chanez P; Pinet C; Jebrak G; Brinchault G; Court-Fortune I; Paillasseur JL; Roche N;
Respir Med; 2013 Feb; 107(2):233-41. PubMed ID: 23098687
[TBL] [Abstract][Full Text] [Related]
27. Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease.
Seemungal TA; Harper-Owen R; Bhowmik A; Jeffries DJ; Wedzicha JA
Eur Respir J; 2000 Oct; 16(4):677-83. PubMed ID: 11106212
[TBL] [Abstract][Full Text] [Related]
28. Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease.
Calverley PM; Sanchez-Toril F; McIvor A; Teichmann P; Bredenbroeker D; Fabbri LM
Am J Respir Crit Care Med; 2007 Jul; 176(2):154-61. PubMed ID: 17463412
[TBL] [Abstract][Full Text] [Related]
29. The effects of respiratory muscle training on improvement of the internal and external thoraco-pulmonary respiratory mechanism in COPD patients.
Tout R; Tayara L; Halimi M
Ann Phys Rehabil Med; 2013 Apr; 56(3):193-211. PubMed ID: 23499539
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory changes, recovery and recurrence at COPD exacerbation.
Perera WR; Hurst JR; Wilkinson TM; Sapsford RJ; Müllerova H; Donaldson GC; Wedzicha JA
Eur Respir J; 2007 Mar; 29(3):527-34. PubMed ID: 17107990
[TBL] [Abstract][Full Text] [Related]
31. Quality of life measured by the St George's Respiratory Questionnaire and spirometry.
Weatherall M; Marsh S; Shirtcliffe P; Williams M; Travers J; Beasley R
Eur Respir J; 2009 May; 33(5):1025-30. PubMed ID: 19164350
[TBL] [Abstract][Full Text] [Related]
32. Relationships between general health measured with the sickness impact profile and respiratory symptoms, physiological measures, and mood in patients with chronic airflow limitation.
Jones PW; Baveystock CM; Littlejohns P
Am Rev Respir Dis; 1989 Dec; 140(6):1538-43. PubMed ID: 2604285
[TBL] [Abstract][Full Text] [Related]
33. Inspiratory capacity and forced expiratory volume in the first second in exacerbation of chronic obstructive pulmonary disease.
Yetkin O; Gunen H
Clin Respir J; 2008 Jan; 2(1):36-40. PubMed ID: 20298302
[TBL] [Abstract][Full Text] [Related]
34. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M;
N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213
[TBL] [Abstract][Full Text] [Related]
35. Correlation between bronchodilator responsiveness and quality of life in chronic obstructive pulmonary disease.
Omata M; Wakabayashi R; Kudoh S; Kida K
Allergol Int; 2007 Mar; 56(1):15-22. PubMed ID: 17259805
[TBL] [Abstract][Full Text] [Related]
36. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
Kömüs N; Tertemiz KC; Sevinç C
Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
[TBL] [Abstract][Full Text] [Related]
37. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial.
Zheng JP; Wen FQ; Bai CX; Wan HY; Kang J; Chen P; Yao WZ; Ma LJ; Li X; Raiteri L; Sardina M; Gao Y; Wang BS; Zhong NS;
Lancet Respir Med; 2014 Mar; 2(3):187-94. PubMed ID: 24621680
[TBL] [Abstract][Full Text] [Related]
38. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.
Belman MJ; Botnick WC; Shin JW
Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581
[TBL] [Abstract][Full Text] [Related]
39. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study.
Miravitlles M; Ferrer M; Pont A; Zalacain R; Alvarez-Sala JL; Masa F; Verea H; Murio C; Ros F; Vidal R;
Thorax; 2004 May; 59(5):387-95. PubMed ID: 15115864
[TBL] [Abstract][Full Text] [Related]
40. A novel, short, and simple questionnaire to measure health-related quality of life in patients with chronic obstructive pulmonary disease.
Hajiro T; Nishimura K; Jones PW; Tsukino M; Ikeda A; Koyama H; Izumi T
Am J Respir Crit Care Med; 1999 Jun; 159(6):1874-8. PubMed ID: 10351933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
